Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies

Journal of Neuroscience Research

Volumn 56, Issue 4, 1999, Pages 405-419

  Diehlmann, Anke ^a,e   Ida, Nobuo ^a   Weggen, Sascha ^b   Grünberg, Jürgen ^c   Haass, Christian ^c   Masters, Colin L ^d   Bayer, Thomas A ^b   Beyreuther, Konrad ^a  

^a ZMBH   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Apoptosis; Human cell lines; Reactive astrocytes

Indexed keywords

PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT;

ALZHEIMER DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; ASTROCYTES; BRAIN; CELL LINE; CROSS REACTIONS; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR WEIGHT; MUTATION; NEURONS; ORGANELLES; PEPTIDE FRAGMENTS; PRESENILIN-1; PRESENILIN-2; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; SENILE PLAQUES; TRANSFECTION;

EID: 0033562741     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990515)56:4<405::AID-JNR8>3.0.CO;2-F     Document Type: Article

References (54)

1. Abelson HT, Rabstein LS. 1970. Influence of prednisolone on moloney leukemogenic virus in BALB/c mice. Cancer Res 2208-2212.
2. Baumeister R, Leimer U, Zweckbronner I, Jakubek C, Grünberg J, Haass C. 1997. The sel-12 mutant phenotype of Caenorhabditis elegans is rescued independent of proteolytic processing by wild-type but not mutant presenilin. Genes Funct 1:149-159
3. Bayer TA, Fossgreen A, Czech C, Beyreuther K, Wiestler OD. 1996. Plaque formation in brain transplants exposed to human beta-amyloid precursor protein 695. Acta Neuropathol 92:130-137.
4. Beher D, Elle C, Underwood J, Davis JB, Ward R, Karran E, Masters CL, Beyreuther K, Multhaup G. 1999. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J Neurochem. In press.
5. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG. 1996. Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013.
6. Busciglio J, Hartmann H, Lorenzo A, Wong C, Baumann K, Sommer B, Staufenbiel M, Yankner BA. 1997. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J Neurosci 17:5101-5107.
7. Capell A, Grünberg J, Pesold B, Diehlmann A, Citron M, Nixon R, Beyreuther K, Selkoe DJ, Haass C. 1998. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 273:3205-3211.
8. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George Hyslop P, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67-72.
9. Cook DG, Sung JC, Golde TE, Felsenstein KM, Wojczyk BS, Tanzi RE, Trojanowski JQ, Lee VMY, Doms RW. 1996. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc Natl Acad Sci USA 93:9223-9228.
10. De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K, Cordell B, Moechars D, Bollen M, Fraser P, St George-Hyslop P, Van Leuven F. 1997. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem 272:3590-3598.
11. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F. 1998. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387-390.
12. Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M, Selkoe DJ, Seeger M, Gandy SE, Price DL, Sisodia SS. 1996. Protein topology of presenilin 1. Neuron 17:1023-1030.
13. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Pereztur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. 1996. Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
14. Giannakopoulos P, Bouras C, Kovari E, Shioi J, Tezapsidis N, Hof PR, Robakis NK. 1997. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am J Pathol 150:429-436.
15. Grünberg J, Walter J, Loetscher H, Deuschle U, Jacobsen H, Haass C. 1998. C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry 273:3205-3211.
16. Haass C. 1997. Presenilins: genes for life and death. Neuron 18:687-690.
17. Hardy J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159.
18. Huynh DP, Vinters HV, Ho DH, Ho VV, Pulst SM. 1997. Neuronal expression and intracellular localization of presenilins in normal and Alzheimer disease brains. J Neuropathol Exp Neurol 56:1009-1017.
19. Kim T-W, Tanzi RE. 1997. Presenilins and Alzheimer's disease. Curr Opin Neurobiol 7:683-688.
20. Kim T-W, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE. 1997. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem 272:11006-11010.
21. Kohler G, Milstein C. 1975, Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (5517): 495-7.
22. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, Wasco W. 1996. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 2:224-229.
23. Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim G, Gandy SE, Seeger M, Koo E, Price DL, Sisodia SS. 1996. Expression of presenilin 1 and 2 in human and murine tissues. J Neurosci 16:7513-7525.
24. Lehmann S, Chiesa R, Harris DA. 1997. Evidence for a six-membrane domain structure of presenilin 1. J Biol Chem 272:12047-12051.
25. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, Hincapie L, Arango JCL, Anthony DC, Koo EH, Goate AM, Selkoe DJ, Arango JCV. 1996. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med 2:1146-1150.
26. Levey AI, Heilman CJ, Lah JJ, Nash NR, Rees HD, Wakai M, Mirra SS, Rye DB, Nochlin D, Bird TD, Mufson EJ. 1997. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease. Ann Neurol 41:742-753.
27. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, Sisodia SS, Greenwald I. 1996. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci US A 93:14940-14944.
28. Li XJ, Greenwald I. 1996. Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17:1015-1021.
29. Li XJ, Greenwald I. 1998. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc Natl Acad Sci USA 95:7109-7114.
30. Loetscher H, Deuschle U, Brockhaus M, Reinhardt D, Nelboeck P, Mous J, Grünberg J, Haass C, Jacobsen H. 1997. Presenilins are processed by caspase-type proteases. J Biol Chem 272:20655-20659.
31. McKay RDG, Valtz N, Cunningham M, Hayes T. 1990. Mechanisms regulating cell number and type in the mammalian central nervous system. Cold Spring Harbor Symp Quant Biol 55:291-301.
32. Mercken M, Takahashi H, Honda T, Sato K, Murayama M, Nakazato Y, Noguchi K, Imahori K, Takashima A. 1996. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett 389:297-303.
33. Paffenholz R, Franke WW. 1997. Identification and localization of a neurally expressed member of the plakoglobin/armadillo multi-gene family. Differentiation 61:293-304.
34. Perez-Tur J, Croxton R, Wright K, Phillips H, Zehr C, Crook R, Hutton M, Hardy J, Karran E, Roberts GW, Lancaster S, Haltia T. 1996. A further presenilin 1 mutation in the exon 8 cluster in familial Alzheimer's disease. Neurodegeneration 5:207-212.
35. Podlinsky MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, Diehl T, Levesque G, Fraser P, Haass C, Koo EH, Seubert P, St George Hyslop P, Teplow DB, Selkoe DJ. 1997. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 3:325-337.
36. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, et al. 1995. Familial Alzheimer's disease in kindred's with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
37. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870.
38. Selkoe DJ. 1996. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298.
39. Sherrington R, Rogaev El, Liang Y, Rogaeva RA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
40. Shihabuddin LS, Brunschwig JP, Holets VR, Bunge MB, Whittemore SR. 1996. Induction of mature neuronal properties in immortalized neuronal precursor cells following grafting into neonatal CNS. J Neurocytol 25:101-111.
41. Suzuki T, Nishiyama K, Murayama S, Yamamoto A, Sato S, Kanazawa I, Sakaki Y. 1996. Regional and cellular presenilin I gene expression in human and rat tissues. Biochem Biophys Res Commun 219:708-713.
42. Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W. 1996. The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 3:159-168.
43. Tesco G, Kim T-W, Diehlmann A, Beyreuther K, Tanzi RE. 1998. Abrogation of the presenilin 1/β-catenin interaction and preservation of the heterodirneric presenilin 1 complex following caspase activation. J Biol Chem 273:33909-33914.
44. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia Ss. 1996. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17:181-190.
45. Tomita T, Maruyama K, Saido TC, Kume H, Shinozaki K, Tokuhiro S, Capell A, Walter J, Grunberg J, Haass C, Iwatsubo T, Obata K. 1997. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci USA 94:2025-2030.
46. Walter J, Capell A, Grünberg J, Pesold B, Schindzielorz A, Prior R, Podlisny MB, Fraser P, Hyslop PS, Selkoe DJ, Haass C. 1996. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol Med 2:673-691.
47. Walter J, Grünberg J, Capell A, Pesold B, Schindzielorz A, Citron M, Mendia K, George Hyslop PS, Multhaup G, Selkoe DJ, Haass C. 1997. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc Natl Acad Sci USA 94:5349-5354.
48. Ward RV, Davies JB, Gray CW, Barton AJL, Bresciani LG, Caivano M, Murphy VF, Duff D, Hutton M, Hardy J, Roberts GW, Karran EH. 1996. Presenilin-1 is processed into two major cleavage products in neuronal cell lines. Neurodegeneration 5:293-298.
49. Weggen S, Diehlmann A, Czech C, Ida N, Weidemann A, Masters CL, Wiestler OD, Beyreuther K, Bayer TA. 1997. Characterization of presenilin overexpressing cerebellar neuronal cells. Soc Neurosci Abstr. Nr. 1888, Volume 1997.
50. Weggen S, Diehlmann A, Buslei R, Beyreuther K, Bayer TA. 1998. Prominent expression of presenilin-1 in reactive astrocytes in Alzheimer's disease brain. NeuroReport 9:3279-3283.
51. Wisniewski T, Dowjat WK, Permanne B, Palha J, Kumar A, Gallo G, Frangione B. 1997. Presenilin-1 is associated with Alzheimer's disease amyloid. Am J Pathol 151:601-610.
52. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH, Sisodia SS. 1997. Presenilin 1 is required for Notch I and Dili expression in the paraxial mesoderm. Nature 387:288-292.
53. Xia W, Zhang J, Perez R, Koo EH, Selkoe DJ. 1997. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc Natl Acad Sci US A 94:8208-8213.
54. Zhou J, Medina M, Ho C, Simmons AD, Lovett M, Kosik KS. 1997. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. NeuroReport 8:2085-2090.